Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

96 Well Microplates with 3D Epoxy Surface

Published: Monday, August 12, 2013
Last Updated: Monday, August 12, 2013
Bookmark and Share
Ideal platform for covalent binding of biomolecules.

Greiner Bio-One has developed 96 well microplates with a 3D epoxy surface in collaboration with its longstanding cooperation partner PolyAn.

The 3D epoxy surface is the ideal platform for covalent binding of proteins, peptides, DNA and oligonucleotides.

The three-dimensional functional matrix allows the development of covalent binding of nucleophiles to the plate surface without complex coupling chemistry.

The structure of the matrix, which has a thickness of up to 50 nm, also reduces unspecific binding to a minimum.

The three-dimensional epoxy 96 well microplates are used mainly if adsorptive binding of peptides or oligonucleotides, for example, to high/medium binding surfaces is ineffective or the binding strength is not sufficient.

Areas of application include detection methods such as ELISA, ELI-Spot, protein and peptide arrays and DNA binding.

The 3D epoxy surface is chemically and mechanically highly robust and features particularly homogeneous surface functionalisation.

The microplates with a 3D epoxy surface are free of detectable DNases and RNases. The shelf life at room temperature is two years.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Big Plans and 40 Years of Experience
Rudi Vollmer becomes new Technical Managing Director of Greiner Bio-One GmbH, responsible for production and technology.
Tuesday, June 30, 2015
Tradition Meets Innovation -­ Greiner Bio-One Celebrates 50 Successful Years
Company now has over 1,700 employees spread across seven production facilities.
Friday, December 13, 2013
Greiner Bio-One Accelerates HPV Laboratory Diagnostics
At the international congress on HPV (human papilloma virus) and cervical cancer, Greiner Bio-One is presenting the latest clinical study on the PapilloCheck HPV test.
Monday, November 04, 2013
Greiner Bio-One Supplies Laboratory Products for Stem Cell Burger
Production of the first stem cell burger, which recently hit the headlines throughout the world, also owes its success to high-quality laboratory products from Greiner Bio-One.
Wednesday, September 04, 2013
Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Charles River Acquires Agilux
Enhances Charles River’s early-stage capabilities in bioanalytical services.
Scientists Find Lethal Vulnerability in Treatment-Resistant Lung Cancer
The study describes how the drug Selinexor killed lung cancer cells and shrank tumors in mice when used against cancers driven by the aggressive and difficult-to-treat KRAS cancer gene.
How Baby’s Genes Influence Birth Weight And Later Life Disease
The large-scale study could help to target new ways of preventing and treating these diseases.
Genes Underlying Dogs’ Social Ability Revealed
The social ability of dogs is affected by genes that also seem to influence human behaviour, according to a new study from Linköping University in Sweden.
‘Cellbots’ Chase Down Cancer, Deliver Drugs Directly to Tumors
Programmable T cells shown to be versatile, precise, and powerful in lab studies.
Drug to Treat Alcohol Use Disorder Shows Promise Among Drinkers With High Stress
The findings suggest that potential future studies with drugs targeting vasopressin blockade should focus on populations of people with AUD who also report high levels of stress.
C Dots Show Powerful Tumor Killing Effect
Nanoparticles known as Cornell dots, or C dots, have shown great promise as a therapeutic tool in the detection and treatment of cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!